IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 49 filers reported holding IKENA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,251,376 | +3.5% | 1,364,470 | -10.9% | 0.00% | – |
| Q1 2024 | $2,175,680 | -27.6% | 1,532,169 | +0.5% | 0.00% | – |
| Q4 2023 | $3,003,950 | -48.7% | 1,524,848 | +12.7% | 0.00% | – |
| Q3 2023 | $5,858,421 | -18.5% | 1,352,984 | +23.5% | 0.00% | – |
| Q2 2023 | $7,184,315 | +108.5% | 1,095,170 | +9.7% | 0.00% | – |
| Q1 2023 | $3,445,128 | +32.2% | 998,588 | +1.9% | 0.00% | – |
| Q4 2022 | $2,605,515 | -25.0% | 979,517 | +0.1% | 0.00% | – |
| Q3 2022 | $3,475,000 | +16.3% | 979,003 | +45.2% | 0.00% | – |
| Q2 2022 | $2,987,000 | -38.0% | 674,105 | -14.7% | 0.00% | – |
| Q1 2022 | $4,819,000 | -50.9% | 789,999 | +1.0% | 0.00% | – |
| Q4 2021 | $9,811,000 | +25.3% | 782,394 | +26.1% | 0.00% | – |
| Q3 2021 | $7,833,000 | +69.8% | 620,686 | +88.9% | 0.00% | – |
| Q2 2021 | $4,613,000 | +172.2% | 328,612 | +447.7% | 0.00% | – |
| Q1 2021 | $1,695,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $3,711,053 | 2.75% |
| Blue Owl Capital Holdings LP | 4,091,118 | $6,750,345 | 1.88% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $8,279,994 | 0.87% |
| BML Capital Management, LLC | 585,114 | $965,438 | 0.69% |
| Acuitas Investments, LLC | 399,879 | $659,800 | 0.35% |
| Deuterium Capital Management, LLC | 80,578 | $132,954 | 0.22% |
| BVF INC/IL | 4,769,164 | $7,869,121 | 0.22% |
| Orbimed Advisors | 3,539,358 | $5,839,941 | 0.12% |
| NEA Management Company, LLC | 570,050 | $940,583 | 0.07% |
| Sofinnova Investments, Inc. | 382,616 | $631,316 | 0.03% |